Johnson & Johnson said its combination therapy for lung cancer outperformed AstraZeneca Plc’s blockbuster Tagrisso in a ...

Jan. 6, 2025 — Researchers have developed a way of detecting circulating tumor cells in the bloodstream of pancreatic cancer and lung cancer ... Scientists Develop Scans That Light-Up Aggressive ...

CURE compiled the top stories in the lung cancer space, including treatment updates and the potential of cancer vaccines.

Michael Truskoski learned he has stage 4 lung cancer after he had a seizure at work just over three weeks ago, the result of cancer that spread to his brain.

Researchers from the University of Michigan have developed a way of detecting circulating tumor cells in the bloodstream of ...

Lung cancer, notorious for its high mortality rates, is a leading cause of cancer-related deaths globally, with metastasis ...

In an extremely rare case, an unnamed 69-year-old man who had cirrhosis and liver cancer underwent a liver transplant and ...

The lungs are a tempting place for cancer cells -- so much so that more than half of people with advanced cancer elsewh ...

Results from the Mariposa study found a regimen of Rybrevant and Lazcluze helped patients with a common form of advanced lung ...

Johnson & Johnson said a combination of its lung cancer drugs Rybrevant and Lazcluze kept people alive for at least a year longer than AstraZeneca's Tagrisso in a clinical trial. J&J is trying to ...

Lung cancer, notorious for its high mortality rates, is a leading cause of cancer-related deaths globally, with metastasis being the primary contributor to poor patient outcomes.

A couple from a small town outside Peoria celebrated their first Christmas with their new baby after a scary cancer diagnosis ...